tiprankstipranks
Trending News
More News >
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Hong Kong Market

Compare Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.45B
-14.99
276.82%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.20B
58.33
37.04%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$1.93B
238.10
38.89%
Zhaoke Ophthalmology Ltd.
HK$3.17
HK$1.85B
-6.12
159.23%
Immunotech Biopharm Ltd
HK$2.68
HK$1.71B
-6.43
29.32%
Hightide Therapeutics Inc
HK$3.05
HK$1.38B
-3.89
144.14%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
5.95
4.41
286.36%
HK:6998
Genor Biopharma Holdings Limited
2.59
0.76
41.53%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.50
0.70
38.89%
HK:6622
Zhaoke Ophthalmology Ltd.
3.37
2.05
155.30%
HK:6978
Immunotech Biopharm Ltd
2.77
0.70
33.82%
HK:2511
Hightide Therapeutics Inc
2.71
1.66
158.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts